Q32 Bio (QTTB) announced topline results from the SIGNAL-AA Phase 2a signal finding clinical trial evaluating bempikibart, or ADX-914, which identified encouraging clinical activity in patients with ...

KOWLOON, KOWLOON, HONG KONG, September 15, 2025 /EINPresswire.com/ -- Founded by Warren Hanchey, an expert with over five decades of experience in business and bio ...

While metabolomics is the large-scale comprehensive profiling of metabolites and other small molecules in the context of ...

Researchers at the University of Copenhagen have identified a signaling pathway that simultaneously increased energy expenditure and decreased food intake. In both human and primate studies, agonists ...

Wearable Devices expands its AI-powered LMM technology into predictive health monitoring and cognitive state analytics, enhancing real-time health insights. Wearable Devices Ltd., a technology company ...

Combining bio-signaling innovation with sustainable practices to support wellness in electronic-heavy environments. KAOHSIUNG, KAOHSIUNG, TAIWAN, September 19, 2025 ...